Skip to main content

Advertisement

Log in

Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Recent reports suggest a role of hypovitaminosis D in the pathogenesis of inflammatory autoimmune diseases (ARD); we investigated 25(OH)vitamin D plasma level before and after supplementation in ARD and NARD (non-ARD: osteoporosis and/or OA) patients. We retrospectively evaluated 572 consecutive clinical records of adult patients at immuno-rheumatology and rehabilitative units of our institution from January 2006 to October 2009. We excluded patients with vitamin D supplementation or renal failure, primary hyperparathyroidism, liver failure. We recorded 25(OH)vitamin D plasma concentration of 245 patients together with other clinical data. We then evaluated 25(OH)vitamin D plasma concentration of 100 (43 ARD and 57 NARD) patients previously included who underwent 750–1,000 UI/die 25(OH)vitamin D supplementation for at least 6 months. Appropriate statistical analysis was performed. The median 25(OH)vitamin D concentration was not significantly different between 119 ARD [33.4 (IQR 22.5–54.9) nmol/l] and 126 NARD patients 32.9 (IQR 18.7–50.2). In stepwise logistic regression, female sex (F:13.7), winter-spring season (F:5.6) and older age (F:5.3), but not ARD, predicted plasma 25(OH)vitamin D <75 nmol/l. Cholecalciferol supplementation increased 25(OH)vitamin D plasma concentration equally in both ARD and NARD; however, only 29/100 patients reached a plasma level ≥75 nmol/l without differences between ARD and NARD (χ2 = n.s.). Hypovitaminosis D is common in rheumatic patients. Sex and age but not ARD are risk factors for this condition. 750–1,000 UI/die of cholecalciferol is not sufficient to normalize plasma level in these patients. Increase of plasma 25(OH)vitamin D after treatment is not influenced by the presence of an inflammatory autoimmune disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062–2072

    Article  PubMed  CAS  Google Scholar 

  2. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716

    Article  PubMed  CAS  Google Scholar 

  3. Sunyecz JA (2008) The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag 4:827–836

    PubMed  CAS  Google Scholar 

  4. Lemire JM (1992) Immunomodulatory role of 1, 25-dihydroxyvitamin D3. J Cell Biochem 49:26–31

    Article  PubMed  CAS  Google Scholar 

  5. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270:701–708

    Article  PubMed  CAS  Google Scholar 

  6. Helming L, Böse J, Ehrchen J, Schiebe S, Frahm T, Geffers R et al (2005) 1alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106:4351–4358

    Article  PubMed  CAS  Google Scholar 

  7. van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101

    Article  PubMed  Google Scholar 

  8. Holick MF (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29:361–368

    Article  PubMed  CAS  Google Scholar 

  9. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 50:72–77

    Article  PubMed  CAS  Google Scholar 

  10. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149

    Article  PubMed  CAS  Google Scholar 

  11. Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME et al (2006) Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24:702–704

    PubMed  CAS  Google Scholar 

  12. Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B et al (2007) Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62:440–446

    Article  PubMed  Google Scholar 

  13. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K (2005) Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 16:1425–1431

    Article  PubMed  CAS  Google Scholar 

  14. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28

    PubMed  CAS  Google Scholar 

  15. Cutolo M (2009) Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) 48:210–212

    Article  CAS  Google Scholar 

  16. Lips P (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103:620–625

    Article  PubMed  CAS  Google Scholar 

  17. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14:577–582

    Article  PubMed  CAS  Google Scholar 

  18. Mouyis M, Ostor AJ, Crisp AJ, Ginawi A, Halsall DJ, Shenker N et al (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford) 47:1348–1351

    Article  CAS  Google Scholar 

  19. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E (2008) Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 67:530–535

    Article  PubMed  CAS  Google Scholar 

  20. Nielen MM, van Schaardenburg D, Lems WF, van de Stadt RJ, de Koning MH, Reesink HW et al (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum 54:3719–3720

    Article  PubMed  Google Scholar 

  21. Craig SM, Yu F, Curtis JR, Alarcón GS, Conn DL, Jonas B et al (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol 37:275–281

    Article  PubMed  CAS  Google Scholar 

  22. Talwar SA, Aloia JF, Pollack S, Yeh JK (2007) Dose response to vitamin D supplementation among post-menopausal African American women. Am J Clin Nutr 86:1657–1662

    PubMed  CAS  Google Scholar 

  23. von Restorff C, Bischoff-Ferrari HA, Theiler R (2009) High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 45:747–749

    Article  Google Scholar 

  24. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E et al (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93:3015–3020

    Article  PubMed  CAS  Google Scholar 

  25. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S (1999) Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr 81:133–137

    Article  PubMed  CAS  Google Scholar 

  26. Reuch J, Ackermann H, Badenhoop K (2009) Cyclic changes of vitamin D and pth are primarily regulated by solar radiation: 5-year analysis of German (50 degrees N) population. Horm Metab Res 41:402–407

    Article  Google Scholar 

  27. Jacques PF, Felson DT, Tucker KL, Mahnken B, Wilson PW, Rosenberg IH et al (1997) Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr 66:929–936

    PubMed  CAS  Google Scholar 

  28. Lanske B, Razzaque MS (2007) Vitamin D and aging: old concepts and new insights. J Nutr Biochem 18:771–777

    Article  PubMed  CAS  Google Scholar 

  29. MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536–1538

    Article  PubMed  CAS  Google Scholar 

  30. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69:20–28

    Article  PubMed  CAS  Google Scholar 

  31. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S et al (2001) Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 12:1026–1030

    Article  PubMed  CAS  Google Scholar 

  32. Rockell JE, Skeaff CM, Williams SM, Green TJ (2006) Serum 25-hydroxy vitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int 17:1382–1389

    Article  PubMed  CAS  Google Scholar 

  33. Saintonge S, Bang H, Gerber LM (2009) Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: the national health and nutrition examination survey III. Pediatrics 123:797–803

    Article  PubMed  Google Scholar 

  34. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC et al (2007) Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha, 25-dihydroxyvitamin D3. Bone 40:1517–1528

    Article  PubMed  CAS  Google Scholar 

  35. Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am 39:365–379

    Article  CAS  Google Scholar 

  36. Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M et al (2010) T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 107:22593–22598

    Article  PubMed  CAS  Google Scholar 

  37. Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tiss Int 62:193–198

    Article  CAS  Google Scholar 

  38. Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035

    Article  PubMed  CAS  Google Scholar 

  39. Ebert R, Jovanovic M, Ulmer M, Schneider D, Meissner-Weigl J, Adamski J et al (2004) Down-regulation by nuclear factor kappaB of human 25-hydroxy vitamin D3 1alpha-hydroxylase promoter. Mol Endocrinol 18:2440–2450

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was supported by “Università del Piemonte Orientale Ricerca Locale” research grants.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pier Paolo Sainaghi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sainaghi, P.P., Bellan, M., Carda, S. et al. Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. Rheumatol Int 32, 3365–3372 (2012). https://doi.org/10.1007/s00296-011-2170-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2170-x

Keywords

Navigation